USACIG, maker of the "Electric Cigarette" announced they have signed an exclusive agreement with Hop-on to submit it's electronic cigarette technology to the FDA for clinical studies for the prevention and treatment of Parkinson's disease.
Recent studies by the Parkinson's Institute and Clinical Center lead by Maryka Quik, Ph D have indicated intermittent nicotine treatment can reduce medication induced dyskinesias by as much as 50%. USACIG is hoping their electronic cigarette might be the perfect way to deliver nicotine to Parkinson's patients.
Peter Michaels, CEO of Hop-on, the company one usually associates with multi media services, the first disposable cell phone and the licencing of technology like CDMA, GSM and WIFI, says they are excited to be the exclusive agent for FDA submission.